INVESTIGATION: Big Pharma's $4.7 Billion Lobbying Machine Exposed
A comprehensive MAHA Daily investigation reveals that pharmaceutical companies have spent over $4.7 billion on federal lobbying over the past decade, employing more lobbyists than there are members of Congress.
Our analysis of OpenSecrets data and lobbying disclosures shows the industry maintains 1,800+ registered lobbyists in Washington—that's more than 3 lobbyists for every senator and representative.
Follow the Money
- Pfizer: $98 million in lobbying (2015-2025)
- Johnson & Johnson: $87 million
- Merck: $82 million
- AbbVie: $71 million
- Bristol-Myers Squibb: $63 million
Campaign Contributions
Beyond lobbying, pharmaceutical PACs and executives contributed over $90 million to congressional campaigns in the 2024 cycle alone, with donations flowing to members of key health committees regardless of party.
Our analysis found that legislators receiving the most pharmaceutical money were significantly more likely to vote against drug pricing reform and for liability protections.
MAHA Daily Editorial: This is why nothing changes. Our government has been purchased by the pharmaceutical industry. Use our Scorekeeper to see exactly how much your representative has taken—and hold them accountable.
